Our discovery of the BRCA2 cancer gene
In 1995, our researchers discovered the cancer gene BRCA2, which, when mutated, can make carriers more likely to develop cancer. This discovery means that families can now assess their cancer risk through genetic testing.
Some people with BRCA mutations can be closely monitored or choose to take preventative measures, such as actress Angelina Jolie.
25th anniversary
On the 25th anniversary of our discovery of the BRCA2 gene, we’ve compiled news stories, blog posts and videos on our pioneering research into BRCA genes. Join the conversation on Twitter: #BRCA2Anniversary
What are the BRCA genes
BRCA1 and BRAC2 are genes that we all carry. These genes normally protect us against cancer. But if you inherit mutations of these genes - ‘faulty’ versions that don’t work as they should - this increases your risk of developing cancer.
People with mutations in BRCA1 and BRCA2 genes are at increased risk of developing certain cancers, including:
- breast cancer, in women and men
- ovarian, fallopian tube, prostate, pancreatic and lung cancers, and
malignant melanoma.
Cancer prevention and treatment
Our research into BRCA genes has led to discoveries for cancer prevention and treatment. This includes better diagnostic and risk testing, the development of a new class of drugs and new targeted therapies for related cancers.
Related pages
Latest ICR News
Breast cancer test predicts relapse risk in just two weeks – and could spare thousands of patients from unnecessary treatment
Thousands of women with breast cancer could be spared unnecessary treatment, thanks to a simple test which can identify whether or not their cancer is likely to return – just two weeks after starting treatment.
Targeted radiotherapy just as effective for low-risk breast cancer and reduces risk of side effects
Thousands of women who undergo radiotherapy for low-risk breast cancer could be spared some of the side effects of treatment after a study confirmed that more targeted treatments are just as effective at controlling the disease in the long term.